BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36288915)

  • 41. Optimization of pleural multisite anesthetic technique during CT-guide microwave ablation of peripheral lung malignancy for improving treatment tolerance.
    Hu H; Gao F; Guo J; Teng G; Wang Z; Zhai B; Liu R; Chi J
    Int J Hyperthermia; 2022; 39(1):822-828. PubMed ID: 35786169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H; Chi JC; Liu R; Zhai B
    Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.
    Yang H; Yang Y; Dou J; Cui R; Cheng Z; Han Z; Liu F; Yu X; Zhou X; Yu J; Liang P
    Cancer Biol Med; 2020 May; 17(2):478-491. PubMed ID: 32587783
    [No Abstract]   [Full Text] [Related]  

  • 45. Novel Image-Guided Flexible-Probe Transbronchial Microwave Ablation for Stage 1 Lung Cancer.
    Pritchett MA; Reisenauer JS; Kern R; Wilson DS; Meyers EE; Szapary PO; Laeseke PF
    Respiration; 2023; 102(3):182-193. PubMed ID: 36652940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial pneumothorax for pain relief during microwave ablation of subpleural lung tumors.
    Yang X; Zhang K; Ye X; Zheng A; Huang G; Li W; Wei Z; Wang J; Han X; Ni X; Meng M; Ni Y; Yuan Q; Xing C
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e80-3. PubMed ID: 26728680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy of systemic chemotherapy combined with radiofrequency ablation and microwave ablation for lung cancer: a comparative study.
    Xu F; Song J; Lu Y; Wang J; Wang J; Xiao H; Li Z
    Int J Hyperthermia; 2021; 38(1):900-906. PubMed ID: 34148500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term outcome following microwave ablation of early-stage non-small cell lung cancer.
    Zhao H; Steinke K
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):787-793. PubMed ID: 32720747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
    Safi S; Rauch G; op den Winkel J; Kunz J; Schneider T; Bischof M; Heussel CP; Huber PE; Herth FJ; Dienemann H; Hoffmann H
    Respiration; 2015; 89(6):550-7. PubMed ID: 25968471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer.
    Li Y; Chen Z; Tian S; Han X; Wang C; Wang Y; Liu B
    BMC Cancer; 2024 Apr; 24(1):481. PubMed ID: 38627695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
    Iguchi T; Hiraki T; Matsui Y; Mitsuhashi T; Katayama N; Katsui K; Soh J; Sakurai J; Gobara H; Toyooka S; Kanazawa S
    J Vasc Interv Radiol; 2020 Jul; 31(7):1044-1051. PubMed ID: 32471699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
    Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
    Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microwave ablation or plus monochemotherapy in elderly advanced non-small-cell lung cancer patients.
    Wei Z; Li Q; Ye X; Yang X; Huang G; Li W; Wang J; Han X
    Minim Invasive Ther Allied Technol; 2021 Apr; 30(2):106-114. PubMed ID: 31621453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computed tomography-guided percutaneous microwave ablation of patients 75 years of age and older with early-stage nonsmall cell lung cancer.
    Han X; Yang X; Ye X; Liu Q; Huang G; Wang J; Li W; Zheng A; Ni Y; Men M
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e56-60. PubMed ID: 26728675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
    Zhu ZY; Yuan M; Yang PP; Xie B; Wei JZ; Qin ZQ; Qian Z; Wang ZY; Fan LF; Qian JY; Tan YL
    World J Surg Oncol; 2022 Jun; 20(1):192. PubMed ID: 35689233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.
    Zheng H; Xu C; Wang X; Li J; Zhao X; Qi J; Feng Y; Zhu Q
    Int J Hyperthermia; 2020 Nov; 37(1):1345-1353. PubMed ID: 33289415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microwave ablation of the T1a small renal mass: expanding beyond 3 cm.
    Qiu J; Ballantyne C; Yeaman C; Lange M; Morgan J; Mershon JP; Richie I; DeNovio A; Clements MB; Krupski TL; Schenkman N; Lobo JM
    Abdom Radiol (NY); 2023 Aug; 48(8):2695-2704. PubMed ID: 37212853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study.
    Cheng M; Fay M; Steinke K
    Int J Hyperthermia; 2016 May; 32(3):316-23. PubMed ID: 26892261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.